Wajchenberg Marcelo, Luciano Rafael de Paiva, Araújo Ronaldo Carvalho, Martins Délio Eulálio, Puertas Eduardo Barros, Almeida Sandro Soares
Departmentof Orthopedics and Traumatology of Universidade Federal de São Paulo UNIFESP/EPM, São Paulo, SP, Brazil.
Department of Biophysics of Universidade Federal de São Paulo UNIFESP/EPM, São Paulo, SP, Brazil.
Acta Ortop Bras. 2013 May;21(3):170-4. doi: 10.1590/S1413-78522013000300009.
: The I/D polymorphism of angiotensin-converting enzyme (ACE) and R577X of the α-actinin-3 (ACTN3) is related to changes in skeletal muscle function. The aim of this study was to evaluate the distribution of these polymorphisms in a family with multiple members with adolescent idiopathic scoliosis (AIS).
: Evaluated 25 subjects from a family with multiple members with AIS, by collecting 10mL of blood for DNA isolation. The genotyping of the I/D polymorphism of the ACE gene and the R577X of the ACTN3 gene was performed using two specific primers to classify individuals as homozygous or heterozygous.
: Regarding the ACE polymorphism it was found that 19 (76%) subjects were DD and 6 (24%) ID. The prevalence of the D allele was 88% and the I allele was 12%. Regarding the ACTN3 polymorphism there were 6 subjects RR (24%), 11 RX (44%) and 8 XX (32%). The prevalence of the R allele was 23 (46%) and the X allele was 27 (54%).
: There was a difference between the distribution of the polymorphism of ACE and ACTN3 in the family studied. When assessing the ACE polymorphism a higher prevalence of the D allele was observed as compared with the I allele. Level of Evidence III, Cross-sectional, Clinical Trial.
血管紧张素转换酶(ACE)的I/D多态性及α-辅肌动蛋白-3(ACTN3)的R577X与骨骼肌功能变化有关。本研究旨在评估这些多态性在一个有多名青少年特发性脊柱侧凸(AIS)患者的家系中的分布情况。
对一个有多名AIS患者的家系中的25名受试者进行评估,采集10mL血液用于DNA分离。使用两种特异性引物对ACE基因的I/D多态性和ACTN3基因的R577X进行基因分型,以将个体分类为纯合子或杂合子。
关于ACE多态性,发现19名(76%)受试者为DD型,6名(24%)为ID型。D等位基因的患病率为88%,I等位基因的患病率为12%。关于ACTN3多态性;有6名受试者为RR型(24%),11名RX型(...44%)和8名XX型(32%)。R等位基因的患病率为23(46%),X等位基因的患病率为27(54%)。
在所研究的家系中,ACE和ACTN3多态性的分布存在差异。在评估ACE多态性时,观察到D等位基因的患病率高于I等位基因。证据水平III,横断面,临床试验。 (注:原文中“11 RX (44%)”处“...”为疑似遗漏信息未完整翻译)